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Abstract
Background: China is experiencing a dynamic HIV/AIDS epidemic. While serology based surveillance systems have reported
the spread of HIV/AIDS, detailed tracking of its transmission in populations and regions is not possible without mapping it
at the molecular level. We therefore conducted a nationwide molecular epidemiology survey across the country.
Methods: HIV-1 genotypes were determined from 1,408 HIV-positive persons newly diagnosed in 2006. The prevalence of
each genotype was estimated by weighting the genotype’s prevalence from each province- and risk-specific subpopulation
with the number of reported cases in the corresponding subgroups in that year.
Results: CRF07_BC (35.5%), CRF01_AE (27.6%), CRF08_BC (20.1%), and subtype B’ (9.6%) were the four main HIV-1 strains in
China. CRF07_BC and CRF08_BC were the primary drivers of infection among injecting drug users in northeastern and
southeastern China, respectively, and subtype B’ remained dominant among former plasma donors in central China. In
contrast, all four strains occurred in significant proportions among heterosexuals nationwide, pointing to an expansion of
the HIV-1 epidemic from high-risk populations into the general population. CRF01_AE also replaced subtype B as the
principal driver of infection among men-who-have-sex-with-men.
Conclusions: Our study provides the first comprehensive baseline data on the diversity and characteristics of HIV/AIDS
epidemic in China, reflecting unique region- and risk group-specific transmission dynamics. The results provide information
critical for designing effective prevention measures against HIV transmission.
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Introduction
Since the first HIV/AIDS case in China was reported in 1985
[1], an estimated 740,000 individuals have contracted HIV in
China by the end of 2009 [2]. In the last quarter century, the main
drivers of China’s HIV epidemic have shifted considerably, from
blood transmission to sexual transmission. The proportions of
injecting drug users (IDUs), heterosexuals, and men who have sex
with men (MSM) among HIV positive persons have changed from
44.2%, 11.3% and 0.3% in 1985 - 2005 to 25.8%, 55.7% and
8.6% in 2009, respectively [2].
China has experienced several waves of HIV-1 epidemics since
its onset in the late 1980s. In 1989, the first epidemic was among
IDUs in Yunnan province, on China’s southwest border near
Myanmar [3,4]. Subtype B’ (Thailand’s variant of subtype B) [3]
and subtype C were almost concurrently transmitted to Yunnan
from Thailand and India, respectively [5], later generating two
new B/C circulating recombinant forms, CRF07_BC and
CRF08_BC, most likely in Yunnan [6–8]. CRF07_BC spread to
northwestern China along a drug traffic route in around 1993 [8–
10], and CRF08_BC spread eastward to the southern coastal
provinces, Guangxi and Guangdong, in around 1990 [6,8]. IDUs
constituted about 70% of HIV cases reported in early 1990s [11].
However, in the early-mid 1990s, unregulated and unsanitary
commercial plasma collection in central China resulted in an
explosion of HIV-1 subtype B’ among plasma donors in Henan
[12] and then dispersed to other provinces in central China [13–
15]. On the other hand, HIV-1 CRF01_AE was first detected
among heterosexuals and IDUs in Guangdong, Guangxi and
Yunnan around 1996–1997 [16,17], and soon spread through
sexual routes to other provinces along the southeast coast [18,19].
More recently, HIV infections among MSM increased rapidly [2].
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Besides subtype B of US-European origin, CRF01_AE and
CRF07_BC were also identified in MSM populations [20–23].
As HIV-1 transmission patterns in China diversify, there is
increasing need for detailed, comprehensive analysis on the
geographic and demographic distribution of viral genotypes. In
this study, we estimated the likely prevalence and distribution of
HIV-1 genotypes in China, using more than 1,500 specimens
collected throughout China in conjunction with HIV case report
data for various risk groups in the respective provinces. Our results
provide the first comprehensive dataset on the characteristics and
diversity of China’s HIV/AIDS epidemic as related to regional
and risk group-specific transmission patterns.
Methods
Study Population and Sample Collection
A total of 1,513 plasma specimens were collected from HIV-
positive individuals newly diagnosed in 2006 from various risk
groups in 30 of the 31 provinces of mainland China except Hainan
(Table 1). Plasma samples were collected during routine follow-up
visits at local Centers for Disease Control in 2006 - 2008. The
study was conducted in a cross-sectional method using stratified
random sampling by province. The sampling ratio [numbers of
samples collected (b) over numbers of HIV case reports (a)] for
each province is shown in Table 1 (column b/a). For provinces
with fewer reported cases, higher sampling ratios were used to
assure statistical confidence; the median sampling ratios for
provinces with ,200, 200–499, 500–999, 1,000–3,999, and
.4000 cases were 22.1%, 16.4%, 9.5%, 2.9% and 2.1%,
respectively (Table 1). No HIV-2 infections were identified in this
study. The study was approved by the institutional review boards
of the National Center for AIDS/STD Control and Prevention.
Written informed consent was obtained from all study partici-
pants.
The study subjects represent all known major risk groups for
HIV infection in China. The risk groups include heterosexuals
(n = 705), MSM (n= 137), IDU (n= 446), former plasma donors
(FPD) (n = 80), blood transfusion (BT) recipients (n = 34), mother
to child transmission (MCT) (n= 22), other (n = 6) and unknown
(n = 83). The 30 provinces are grouped into four regions (Table 1)
according to their proximity and socio-economic status as per
guidelines from the National Bureau of Statistics of China [24,25]:
Northeastern (n = 101); Eastern (n = 448); Central (n = 303); and
Western (n= 661) regions. In our analysis, we further divided the
Western region into Northwestern (n = 240) and Southwestern
(n = 421) sub-regions. The boundaries of the respective regions are
depicted in Fig. 1.
Sequence Analysis and Subtype Determination
HIV-1 nucleotide sequences of 1.1-kb gag (HXB2:781–1836 nt)
and 540-bp env (HXB2:7002–7541 nt) regions were PCR-ampli-
fied and sequenced as described by Cheng et al [26]. HIV-1
genotypes were determined based on neighbor-joining tree
analysis in comparison with Los Alamos 2010 HIV-1 subtyping
references (http://www.hiv.lanl.gov). Phylogenetic analysis was
performed using MEGA4 software with bootstrapping of 1,000
replications [27]. The recombinants were analyzed and confirmed
with Simplot version 3.5.1 [28]. The HIV-1 genotype of each
patient was assigned based on the genotypes of both the gag and env
genes; if only one gene region was available, the genotype of that
region was assigned. Samples with different genotypic identifica-
tion assigned to the gag and env regions were deemed discordant,
and labeled by the gag/env genotype designations (e.g.
CRF01_AE/B).
Data Stratification and Calculation
Since the transmission of HIV, and therefore the distribution of
genotypes, is strongly associated with the geographic location and
risk group status of infective individuals [29], we defined the basic
unit of our analysis (a subgroup) as each particular risk population
in a given province. We defined the proportion of an HIV-1
genotype within each subgroup as its proportion among the
samples obtained for each subgroup. We then determined the
estimated number of individuals for each genotype in a subgroup by
multiplying the calculated proportion with the total number of
HIV cases reported in the subgroup. For a subgroup in which no
specimen was obtained, the number of reported cases was
removed from the 2006 reported total. The adjusted totals and
corresponding sampling ratios for each province is listed in the last
two columns [(d) and (c/d)] of Table 1. The actual calculation
process is shown in Table S1.
The estimated number of individuals infected with each
genotype in each risk group nationwide was obtained by summing
the subgroups across all provinces (Table 2). Similarly, the
estimated proportions and numbers of individuals infected with
each genotype in each geographic region and nationwide were
obtained by summing up the subgroups accordingly (Table 2 and
3).
Results
Distribution of HIV-1 Genotypes in China
A total of 1,404 HIV-1 genotypes of the 1.1-kb gag and/or the
540-bp env regions were determined from 1,513 plasma specimens
collected from newly diagnosed HIV-positive persons in 2006
(Table 1). 1,290 gag genotypes (85.3% of samples) and 1,186 env
genotypes (78.4%) were obtained, and both gag and env genotypes
were available for 1,072 samples (70.9%). There appears to be no
significant bias in the success rates of genotyping due to preferred
amplification of particular genotypes over others. In calculating
the prevalence of HIV-1 genotypes, we weighted the sampled
prevalences with the size of the corresponding risk group in any
given province; if no specimen was obtained for the risk- and
province-specific subgroup, the case count for that subgroup was
removed from the analysis (Methods, also see Table S1). This
removed 5.6% (2,030 of 36,167) of all reported cases from the
national total [(d) in Table 1].
A total of ten major HIV-1 subtypes and circulating
recombinant forms, including subtypes A, B, B’, C, and G, and
CRF01_AE, CRF02_AG, CRF06_cpx, CRF07_BC, and
CRF08_BC, were detected in the study (Table 2). CRF07_BC,
CRF01_AE, CRF08_BC, and subtype B’ were the four pre-
dominant HIV-1 subtypes circulating in China, accounting for
35.5%, 27.5%, 20.2%, and 9.6% of all infections, respectively
(Table 2). These four subtypes alone constituted 92.8% of reported
HIV infections in China that year. Minor HIV-1 genotypes
included subtypes A (0.06%), B (1.05%), C (1.55%), G (0.03%),
CRF02_AG (0.09%), and CRF06_cpx (0.01%). The remaining
4.4% of the samples showed genotype discordance between gag
and env regions: BC (1.84%); BC/CRF01_AE (1.06%);
CRF01_AE/C (0.65%); CRF01_AE/BC (0.40%); CRF01_AE/
B (0.27%); C/CRF01_AE (0.17%). In the following analysis, we
defined the most prevalent discordant genotype (BC) as the
eleventh genotype designation, and all other discordant genotypes
(2.6%) as the twelfth (Table 2).
HIV-1 Genotype Distribution by Risk Group
As summarized in Table 2, IDUs and heterosexuals were the
largest risk populations, which accounted for 50.4% and 34.7% of
HIV-1 Genotype Distribution in China
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estimated HIV infections in 2006, respectively, followed by FPDs
and BT recipients (combined) (FPD+BT) (3.8%), MSM (2.1%),
MCT (0.9%), and other (0.4%) and unknown risk groups (7.8%).
CRF07_BC (48.5%), CRF08_BC (23.6%) and CRF01_AE
(21.2%) were the three main HIV-1 subtypes circulating among
IDUs, accounting for 93.3% of infections in this risk group
(Table 2). Genotypic diversity was the greatest among hetero-
sexuals, in which all twelve HIV-1 genotype categories were
detected (Table 2). The most prevalent genotypes among
heterosexuals were CRF01_AE (39.8%), CRF07_BC (21.9%),
CRF08_BC (17.6%), and subtype B’ (11.6%). These 4 HIV-1
subtypes accounted for 90.8% of estimated HIV-1 infections
among heterosexuals (Table 2). Of note, among MSM where HIV
infections are surging recently in China [2], the proportion of
CRF01_AE (55.8%) exceeded than that of subtype B of US-
European origin (21.5%) that predominated previously. In
contrast, subtype B’ predominated among FPD+BT (92.5%)
(Table 2). Various HIV-1 strains were detected among MCT: B’
(34.1%), CRF08_BC (25.0%), CRF07_BC (18.2%), and
CRF01_AE (12.5%), which may reflect the trends among
heterosexuals.
HIV-1 Genotype Distribution by Geographic Region
As summarized in Table 3, HIV-1 infections were the most
concentrated in the western region [(6,200+17,147) of 34,148,
68.4%], followed by eastern (6,970 of 34,148, 20.4%), central
(3,434 of 34,148, 10.1%), and northeastern (397 of 34,148, 1.2%).
Figure 1 illustrates the estimated region- and province-specific
distribution of HIV-1 genotypes (also see Tables 3 and S2). In the
northeastern region, heterosexuals (164 of 397, 41.3%) and MSM
(105 of 397, 26.4%) were two major risk groups, CRF01_AE (138
of 397, 34.8%), B (85 of 397, 21.4%), CRF07_BC (60 of 397,
15.1%) and B’ (47 of 397, 11.8%) were the predominant genotypes
(Table 3). The high proportion of MSM (26.4%) was a unique
feature in this region. Consistent with the high concentration of
MSM, subtype B was detected at a higher proportion (21.4%) in
the northeast than any other regions, although CRF01_AE
infections were now more prevalent among MSM than subtype
B (54.3% and 37.1%, respectively; see Table 3).
In the eastern region, IDUs (3,775 of 6,970, 54.2%) and
heterosexuals (1,888 of 6,970, 27.1%) were the main risk groups
(Table 3), and CRF01_AE (2,999 of 6,970, 43.0%), CRF07_BC
(1,662 of 6,970, 23.8%) and CRF08_BC (1,211 of 6,970, 17.4%)
were major circulating strains. This proportion of genotypes likely
reflects the predominance of IDUs and heterosexuals in this
region.
In the central region, the main risk groups of HIV infections
were heterosexuals (1,240 of 3434, 36.1%), FPD/BT (1,144 of
3,434, 33.3%), and IDUs (807 of 3,434, 23.5%) (Table 3). The
dominance of FPD+BT was unique to this region. Subtype B’
showed the highest prevalence (2,064 of 3,434, 60.1%), followed
by CRF01_AE (880 of 3,434, 25.6%), CRF07_BC (304 of 3,434,
8.9%) and CRF08_BC (89 of 3,434, 2.6%) (Table 3). While
subtype B’ predominated among FPD+BT (1,106 of 1,144,
96.7%), it was also the most prevalent strain among heterosexuals
(736 of 1,240, 59.4%), followed by CRF01_AE (307 of 1,240,
24.8%).
In the northwestern region, IDUs (4,292 of 6,200, 69.2%) were
the most important risk group, followed by heterosexuals (1,192 of
6,200, 19.2%). CRF07_BC predominated (6,043 of 6,200, 97.5%)
Figure 1. Estimated distribution of HIV-1 genotypes in different provinces in China. Distribution of HIV-1 genotypes in each provinces
across mainland China (n = 30), except Hainan, was illustrated based on the dataset tabulated in Table S2.
doi:10.1371/journal.pone.0047289.g001
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in this region as a whole, and was highly prevalent both among
IDUs and heterosexuals: 99.5% (4,271 of 4,292) and 92.2% (1,099
of 1,192), respectively (Table 3).
In the southwestern region, IDUs (8,285 of 17,147, 48.3%) and
heterosexuals (7,361 of 17,147, 42.9%) were the two main risk
groups, contributing almost equally to the epidemic. CRF08_BC
(5,578 of 17,147, 32.5%), CRF01_AE (5,335 of 17,147, 31.1%),
and CRF07_BC (4,053 of 17,147, 23.6%) were three major
circulating strains. Of note, BC (607 of 17,147, 3.5%) and other
discordant genotypes (762 of 17,147, 4.4%) were detected at
significant proportions in this region. They were mostly from
Yunnan [(496+439) of 7,826, 11.9%], Sichuan (230 of 2,540,
9.1%) and Guangxi provinces [(105+87) of 4,936, 3.9%] (Table
S2). This is the region where we observed the highest viral
diversity after the eastern region (Table S2).
The Distribution of China’s Four Major HIV-1 Strains by
Region and Risk Group
Figure 2 illustrates the geographic distributions of the four
major HIV-1 strains (CRF07_BC, CRF08_BC, CRF01_AE, and
subtype B’) that accounted for 92.8% of infections in China (also
see Table 2).
CRF07_BC was detected in 24 of the 30 provinces (except
Fujian, Hebei, Henan, Neimenggu, Shanxi, and Xizang [Tibet]),
accounting for an estimated 35.5% (12,122 of 34,148) of HIV-1
infections in China. Most of CRF07_BC infections (90.0%) were
found in the western and southern provinces of China, including
Xinjiang (5,946 of 12,122, 49.1%), Sichuan (1,634 of 12,122,
13.5%), Yunnan (1,451 of 12,122, 12.0%) and Guangdong (998 of
12,122, 8.2%) (Table S2, Fig. 2A). IDUs and heterosexuals were
the two main risk groups for the spread of CRF07_BC, accounting
for 68.8% (8,344 of 12,122) and 21.4% (2,595 of 12,122),
respectively (Table 2).
While CRF08_BC was identified in 16 provinces in China
(Fig. 2B, Table S2), 92.7% of CRF08_BC infections were detected
in three southern provinces: Yunnan (3,644 of 6,892, 52.9%),
Guangxi (1,762 of 6,892, 25.6%), and Guangdong (983 of 6,892,
14.3%). IDUs (4,064 of 6,892, 59.0%) and heterosexuals (2,082 of
6,892, 30.2%) were the two major risk groups for CRF08_BC
infections (Table 2).
CRF01_AE was identified in 26 provinces (none from Henan,
Qinghai, Shanxi, and Xinjiang). A majority (80.8%) of
CRF01_AE infections were detected in Guangxi (2,634 of 9,388,
28.1%), Guangdong (2,227 of 9,388, 23.7%), Yunnan (1,204 of
9,388, 12.8%), Guizhou (858 of 9,388, 9.1%), and Hunan (664 of
9,388, 7.1%) (Fig.2C, Table S2). Heterosexuals (4,709 of 9,388,
50.2%) and IDUs (3,649 of 9,388, 38.9%) were the main risk
groups of CRF01_AE infections (Table 2).
HIV-1 subtype B’ was identified in 28 provinces (except Ningxia
and Xizang [Tibet]) and was the most wide-spread HIV-1 strain in
China in terms of geographical reach (Fig. 2D). The highest
prevalence of subtype B’ was observed in central and southwestern
China, especially in Henan (1,391 of 3,289, 42.3%), Anhui (319 of
Table 2. Distribution of HIV-1 genotypes in different risk groups in China*.
HIV-1 genotype Risk group Total (%)



















































































































































































































*Numbers in parentheses and square brackets indicate the proportion of the HIV-infected in each subgroup as a percentage of the national total for that risk group and
genotype, respectively. The estimation was done, assuming that HIV case reports reflect the actual prevalence of HIV infection in the respective risk groups and
provinces (see Methods).
doi:10.1371/journal.pone.0047289.t002
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3,289, 9.7%) and Yunnan (295 of 3,289, 9.0%) (Table S2). Due to
the history of subtype B’ transmission in the early-mid 1990s,
FPDs were considered to be a primary risk group infected with
subtype B’ [30]. However, as shown in Table 2, the proportion of
subtype B’ infections was now highest among heterosexuals (1,373
of 3,289, 41.7%), followed by FPD+BT (1,214 of 3,289, 36.9%)
(Table 2). This strongly suggests subtype B’ had spread from FPDs
into the general population [30,31].
Discussion
We conducted a nationwide cross-sectional study on the HIV-1
genotype distribution in China, combining molecular data with
province-specific estimates of the number of HIV infections in
each risk population. Our study revealed a high level of complexity
of the HIV epidemic in China. We detected a total of 10 HIV-1
subtypes and CRFs (Table 2) found in circulation in all continents
of the world. This likely reflects the increasing mobility of people
Table 3. Estimated distribution of HIV-1 genotypes in different risk groups and regions in China.






IDU 36 0 0 0 0 0 0 0 0 0 0 0 36
Heterosexual 21 0 49 24 6 22 15 0 9 3 6 9 164
MSM 0 0 57 3 0 39 0 0 0 0 0 6 105
FPD+BT 3 0 2 6 0 0 0 0 0 0 0 0 11
Other 0 0 0 0 0 16 0 0 0 0 0 0 16
NA 0 8 30 14 0 8 0 0 0 0 5 0 65
Subtotal 60 8 138 47 6 85 15 0 9 3 11 15 397
Eastern IDU 1142 1031 1500 95 0 0 0 0 0 0 0 7 3775
Heterosexual 311 137 966 254 14 36 138 10 13 0 9 0 1888
MSM 38 4 228 37 0 106 0 0 0 0 0 27 440
FPD+BT 0 0 39 94 0 15 0 0 0 0 0 0 148
MCT 0 14 4 5 0 0 0 0 0 0 0 0 23
Other 0 10 3 0 0 0 0 0 0 0 0 0 13
NA 171 15 259 76 0 104 0 0 10 0 0 48 683
Subtotal 1662 1211 2999 561 14 261 138 10 23 0 9 82 6970
Central IDU 163 31 546 62 0 0 5 0 0 0 0 0 807
Heterosexual 93 58 307 736 0 0 28 0 0 0 4 14 1240
MSM 10 0 11 0 0 5 0 0 0 0 0 0 26
FPD+BT 38 0 0 1106 0 0 0 0 0 0 0 0 1144
MCT 0 0 0 96 0 0 0 0 0 0 0 0 96
NA 0 0 16 64 0 0 41 0 0 0 0 0 121
Subtotal 304 89 880 2064 0 5 74 0 0 0 4 14 3434
North
western
IDU 4271 0 10 4 0 0 7 0 0 0 0 0 4292
Heterosexual 1099 6 18 69 0 0 0 0 0 0 0 0 1192
MSM 0 0 8 4 0 0 0 0 0 0 0 0 12
FPD+BT 2 0 0 8 0 0 0 0 0 0 0 0 10
MCT 48 0 0 0 0 0 0 0 0 0 0 0 48
Other 99 0 0 0 0 0 0 0 0 0 0 0 99
NA 524 0 0 23 0 0 0 0 0 0 0 0 547
Subtotal 6043 6 36 108 0 0 7 0 0 0 0 0 6200
South
western
IDU 2732 3001 1593 219 0 0 123 0 0 0 322 295 8285
Heterosexual 1071 1881 3369 290 0 6 106 0 0 0 217 421 7361
MSM 14 0 88 0 0 0 0 0 0 0 0 16 118
MCT 6 60 33 0 0 0 0 0 0 0 0 30 129
NA 230 636 252 0 0 0 68 0 0 0 68 0 1254
Subtotal 4053 5578 5335 509 0 6 297 0 0 0 607 762 17147
doi:10.1371/journal.pone.0047289.t003
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in the country, with over 34 million outbound travelers and 49
million inbound across China’s borders in 2006 [32].
Viral diversity varied considerably in different risk populations
and regions in China. Subtype B’ predominated among FPD+BT
(92.5%) (Table 2), consistent with the region’s history of a single
explosive HIV epidemic due to contamination in commercial
plasma donations in the early-mid 1990s in central China [30].
Similarly, CRF07_BC predominated among IDUs in northwest-
ern China (99.5%) (Table 3), In contrast, we observed the highest
viral diversity among heterosexuals: all 12 genotype categories
were detected in this population (Table 2). Furthermore, as
typically seen in subtype B’ in central China and CRF07_BC in
northwestern China, these two strains were also prevalent among
heterosexuals in the respective regions: B’ (59.4%) in central
China; CRF07_BC (92.2%) in northwestern China (Table 3). This
suggests that the spread of HIV-1 from the particular high-risk
populations (IDUs and FPDs) into general populations was
significantly facilitated through heterosexual transmission in those
regions [30,31,33,34].
As well, differences in viral diversity between geographical
regions point to differences in the drivers of HIV-1 transmission.
CRF07_BC predominated in the northwestern region in the vast
majority of risk groups (over 90%) (Table 3). This was especially
true for Xinjiang: CRF07_BC was the single predominant HIV-1
strain even among heterosexuals, a genotypically diverse risk
group in other regions of the country. This uniformity indicates
a strong regional founder effect in the local HIV epidemic and
suggests a lack of incoming transmissions from other regions. In
contrast, although subtype B’ was the main HIV genotype (60.1%)
in central China, its prevalence was highest in the FPD+BT
population, less so in heterosexuals, and was rarely found amongst
local IDU and MSM (Table 3). Henan province, the center of the
FPD epidemic, was the exception, in which subtype B’
predominated in all risk groups. Infections in all other geo-
graphical regions were driven by multiple HIV-1 genotypes, which
suggest that with a few exceptions, the impact of geographical
communities on HIV transmission was weaker than that of
behavioral communities (i.e. risk groups). Interventions for curbing
new infections may therefore benefit more from implementing risk
behavior-specific measures across geographical boundaries than
from a more regionally focused approach.
Further, changes in the relative prevalence of genotypes
nationwide and among populations of interest illustrate shifts in
China’s HIV transmission patterns. The proportion of subtype B’
amongst all infections has decreased from 47.5% in 1998 and
29.1% in 2002 [35] to 9.6% in 2006, in accordance with national
policies that strictly regulated blood donations since the late 1990s
[36]. However, in 2006, heterosexual contact has overtaken blood
transmission routes as the greatest risk group for subtype B’
infections nationwide (41.7% and 36.9%), and B’ also predomi-
nated amongst heterosexual infections in the central region
(59.4%; Table 3). At the same time, the prevalence of CRF01_AE
Figure 2. Estimated geographic distribution of the four major HIV-1 genotypes in China. Prevalence of the four major HIV-1 genotypes,
including CRF07_BC (A), CRF08_AE (B), CRF01_AE (C) and subtype B’ (D), is estimated for each province by the methods described in Methods.
Corrected prevalence is color-coded as indicated in the inset.
doi:10.1371/journal.pone.0047289.g002
HIV-1 Genotype Distribution in China
PLOS ONE | www.plosone.org 7 October 2012 | Volume 7 | Issue 10 | e47289
infections has increased from 9.6% in 1998 and 15.5% in 2002
[35] to 27.5% in 2006 (Table 2). This is likely related to the
increasing predominance of sexual transmission across the
country. CRF01_AE was the most prevalent HIV-1 strains among
heterosexuals (39.8%) and MSM (55.8%) (Table 2), and was
highly represented in all geographic regions except the northwest-
ern and central regions where local genotypes prevailed (Fig. 1).
Notably, transmission among MSM was previously predominated
by subtype B (of US and European origin) in major cities of China
[2], but has now been eclipsed by the increasing prevalence of
CRF01_AE. This is consistent with previous observations in MSM
population in Beijing [20], Liaoning [21] and Shijiazhuang [22].
These trends underscore the increasing significance of sexual
transmission in China’s HIV/AIDS epidemic.
Our study has several limitations. Sampling bias may have
occurred due to limited sample size in provinces with low HIV-1
prevalence. Bias may also have been introduced during the
adjustment of genotype prevalences for risk- and province-specific
subgroups, which excluded some subgroups of very low prevalence
from calculation (e.g. IDUs in Anhui; see Table S1). Additionally,
risk assessment and attribution are also subject to biases; in
particular, some MSM, commercial sex workers, and commercial
sex clients may be unwilling to disclose their risk status. Future
iterations of the national molecular epidemiologic survey should
aim to more adequately sample each province- and risk-specific
subgroup and to better assess risk statuses.
In summary, our results illustrate the recent state of China’s
HIV/AIDS epidemic, reflecting the country’s unique region- and
risk group-specific transmission patterns. Our data provide
information critical for designing effective interventions to limit
future HIV transmission in China. As current approaches in HIV
vaccine development often remain limited in eliciting immune
responses against wide-ranging viral subtypes [37,38], improved
knowledge of genotype prevalences can help inform vaccine
research and development efforts tailored towards the particular
HIV epidemic profile in China and nearby regions. In addition,
we propose that our method for estimating genotype prevalence
(also see [29]), which links molecular genotyping data with the
numbers of HIV case reports in region- and risk-group specific
subpopulations, may be widely applied to future molecular
epidemiologic analyses. We aim to continue monitoring the trends
in HIV-1 subtype distribution in China to identify and charac-
terize newly emerging properties of public health importance.
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